You may have seen the ads touting the power of online pharmacy sites such as Pharmaprix.com, but they can’t be trusted.
Pharmaprix, an online pharmacy platform for the US, has had a bad reputation over the past few years.
But a new study suggests that Pharmapix, which allows users to fill prescriptions online, may be worth the price of admission.
Researchers at the University of Pennsylvania looked at Pharmapax sales and drug use and found that the site helped people who could’t afford to buy prescription medicines at pharmacies in their home, according to a news release from the university.
PharmaPax sales increased by 20 percent in 2015 and 2016, and the average user spends $50 a month on the platform, according a study by the Center for Drug Evaluation and Research.
Pharmaplex is owned by private equity firm Blackstone Group, which also owns online pharmacies, including Pharmacare.com.
But there is a downside to the Pharmapox brand name.
Pharmacapax also sells its own product, which has a price tag of about $5.25 per day.
That’s about three times the cost of a generic prescription medication, according the researchers.
They also note that pharmacies may not always offer the same price range for generic medication as Pharmacapax does.
Pharcis Pharmaceuticals Inc. said it plans to invest $2 million to expand its pharmacy network.
Phi-Rite Inc. is expanding its pharmacy offerings to include pharmacists, but not as quickly as Pharmaflex, which is set to launch its own pharmacy this year.
Pharacos, the maker of Paxil, said its pharmacy has more than 400 pharmacy locations across the country, which will allow it to better target customers.
PhracyPax, which operates in 37 states, has attracted about 500,000 registered pharmacy users, up from about 500 last year, according an update from the company.
The company said it is currently evaluating its pharmacy inventory and the number of patients it can reach through its online pharmacy.
Pharmafx is expected to have an expanded network of pharmacy locations in the next year, including some in the U.S. The company is also working with pharmacies to build relationships with doctors and hospitals.
Phrasex, a generic drug maker that is also owned by Pfizer Inc., said it will roll out pharmacy-based pharmacy services in the United States by the end of 2019.
Phasex said it recently began testing its pharmacy plans in California, Florida and New Jersey.
PhRMA is a trade group for the pharmaceutical industry that has been pushing for prescription drug prices to rise.
Phrxmox, a company that operates pharmacies, also plans to expand pharmacy sales in the coming year.
The Pharmapedia article has been updated to include the latest research on Pharmaprax and to correct the price.